Inhibition of adrenergic vasoconstriction by quinidine.
D000328:Adult; D000704:Analysis of Variance; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001808:Blood Vessels / Q000187:drug effects*; D003714:Denervation; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D005542:Forearm / Q000098:blood supply; D006339:Heart Rate / Q000187:drug effects; D006614:Hindlimb / Q000294:innervation; D006801:Humans; D008297:Male; D009132:Muscles / Q000098:blood supply / Q000294:innervation; D005996:Nitroglycerin / Q000494:pharmacology; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010477:Perfusion; D011802:Quinidine / Q000494:pharmacology*; D012039:Regional Blood Flow / Q000187:drug effects; D012701:Serotonin / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000187:drug effects*; D013997:Time Factors
D000804:Angiotensin II; D012701:Serotonin; D005996:Nitroglycerin; D011802:Quinidine; D009638:Norepinephrine